Principal Healthcare Innovators ETF (NASDAQ: BTEC) stock price, news, charts, stock research, profile.
Open | $40.03 |
High | $40.03 |
52 Wk High | 41.10 |
AUM | 16.20M |
Dividend | - |
Ex-Div Date | - |
Volume | 269 |
Market Cap | $5.42B |
Mgmt Fee | 0.42% |
P/E Ratio | 24.25 |
Prev. Close | $39.95 |
Low | $40.03 |
52 Wk Low | 25.66 |
Shares Out | 1.07M |
Yield | - |
Div. Freq | - |
Avg. Volume Daily | 14.03K |
Beta | 0.99 |
Avg. Expense Ratio | NA% |
P/B Ratio | 0.52 |
You can purchase shares of Principal Healthcare Innovators ETF (NASDAQ:BTEC) through any online brokerage.
There are no as such competitors for Principal Healthcare Innovators ETF.
There is no analysis for Principal Healthcare Innovators ETF.
There is no analysis for Principal Healthcare Innovators ETF to provide a consensus price target.
The stock price for Principal Healthcare Innovators ETF (NASDAQ: BTEC) is $36.5 last updated Today at June 24, 2024 at 7:14 AM EDT.
A quarterly cash dividend of 0.04 per share of Class A Common Stock. The quarterly cash dividend was payable on December 20, 2017 to stockholders of record on December 15, 2017.
Principal Healthcare Innovators ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Principal Healthcare Innovators ETF.
Sector | Healthcare |
Category | Mid Performer-Mid Growth |
Investment Style | Mid Cap Growth |
Fund Inception | Aug 19, 2016 |
Managers | Aaron J. Siebel Christopher Ibach |
Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Symbol | Name | Share % |
---|---|---|
ALNY | Alnylam Pharmaceutical... | 5.20% |
MRNA | Moderna Inc Restricted... | 3.49% |
SRPT | Sarepta Therapeutics I... | 3.16% |
NTRA | Natera Inc | 2.80% |
ILMN | Illumina, Inc. | 2.46% |
CTLT | Catalent Pharma Soluti... | 2.19% |
INSM | Insmed Inc | 2.15% |
ROIV | Roivant Sciences Ltd | 1.89% |
PCVX | Vaxcyte Inc | 1.79% |
EXAS | Exact Sciences Corp | 1.66% |